CGEN logo

CGENCompugen Ltd

$2.14
$0.125
(5.53%)
Today
Updated: 02:43 PM EDT
Reported EarningsMay 18
Mkt Cap$213.69M
Vol560,625.00
News
all
press releases
Compugen Q1 2026 Earnings Call: Complete Transcript
read more...
Benzinga
News Placeholder
More News
News Placeholder
Compugen Q1 Earnings Call Highlights
Compugen Q1 Earnings Call Highlights...
Yahoo! Finance: News
News Placeholder
Compugen (CGEN) Reports Q1 Loss, Lags Revenue Estimates
Compugen (CGEN) delivered earnings and revenue surprises of -9.14% and -16.95%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
News Placeholder
Compugen Reports First Quarter 2026 Results
Compugen Reports First Quarter 2026 Results Compugen Reports First Quarter 2026 Results PR Newswire HOLON, Israel, May 18, 2026 COM701 MAIA-ovarian trial actively enrolling patients across all...
PR Newswire
News Placeholder
BioXcel Therapeutics, Inc. (BTAI) Reports Q1 Loss, Lags Revenue Estimates
BioXcel Therapeutics (BTAI) delivered earnings and revenue surprises of +8.48% and -28.97%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
News Placeholder
Adherex Technologies Inc. (FENC) Beats Q1 Earnings and Revenue Estimates
Adherex Technologies (FENC) delivered earnings and revenue surprises of +157.14% and +8.36%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
News Placeholder
Compugen to Participate in 2026 Stifel Virtual Targeted Oncology Forum
Compugen to Participate in 2026 Stifel Virtual Targeted Oncology Forum Compugen to Participate in 2026 Stifel Virtual Targeted Oncology Forum PR Newswire HOLON, Israel, May 12, 2026 HOLON, Israel...
PR Newswire
News Placeholder
Janux Therapeutics, Inc. (JANX) Reports Q1 Loss, Lags Revenue Estimates
Janux Therapeutics (JANX) delivered earnings and revenue surprises of +21.83% and -75.11%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
News Placeholder
Compugen (NASDAQ:CGEN) Stock Price Crosses Above 200-Day Moving Average - What's Next?
Compugen (NASDAQ:CGEN) Share Price Crosses Above Two Hundred Day Moving Average - What's Next...
MarketBeat
News Placeholder
BioMarin Pharmaceutical (BMRN) Q1 Earnings Lag Estimates
BioMarin (BMRN) delivered earnings and revenue surprises of -18.96% and +0.50%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
<
1
2
...
>